The Best Poster Award at ESMO GI 2025 – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
“Anuj Patel, MD, recently presented research at ESMO – European Society for Medical Oncology GI, receiving a Best Poster Award for work on a new circulating tumor DNA (ctDNA) test designed to detect minimal residual disease (MRD) in patients who undergo curative treatment for locally advanced esophageal cancer.
The test, developed in collaboration with Harvey Mamon, MD, PhD, Peter Enzinger, MD, G. Mike Makrigiorgos, PhD, and Viktor Adalsteinsson, PhD of the Broad Institute of MIT and Harvard, demonstrated improved detection of MRD. Patel hopes this advancement marks a meaningful step forward in the treatment of esophageal cancer. The research was made possible through philanthropic funding.”
More posts featuring Dana-Farber Cancer Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023